Ebola virus disease in children, Sierra Leone, 2014–2015

Emerging Infectious Diseases

Volumn 22, Issue 10, 2016, Pages 1769-1777

  Fitzgerald, Felicity ^a,b   Naveed, Asad ^a   Wing, Kevin ^c   Gbessay, Musa ^a   Ross, J C G ^a   Checchi, Francesco ^a,c   Youkee, Daniel ^d   Jalloh, Mohammed Boie ^e   Baion, David ^f   Mustapha, Ayeshatu ^f   Jah, Hawanatu ^f   Lako, Sandra ^f   Oza, Shefali ^c   Boufkhed, Sabah ^c   Feury, Reynold ^g   Bielicki, Julia A ^b,h   Gibb, Diana M ^b   Klein, Nigel ^b   Sahr, Foday ^e   Yeung, Shunmay ^c  

^a SAVE THE CHILDREN   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Ministry of Health and Sanitation   (Sierra Leone)

^e Republic of Sierra Leone Armed Forces   (Sierra Leone)

^f Ola During Children's Hospital   (Sierra Leone)

^g Western Area Emergency Response Centre   (Sierra Leone)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; C REACTIVE PROTEIN; INFUSION FLUID; ORAL REHYDRATION SOLUTION; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; HEMOGLOBIN; POTASSIUM; SODIUM; UREA;

AGE; ALOPECIA; ARTHRALGIA; ARTICLE; BLINDNESS; CASE FATALITY RATE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DEATH; DIARRHEA; EBOLAVIRUS; FEMALE; HUMAN; HYPONATREMIA; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVOR; UVEITIS; VIRUS INFECTION; ANOREXIA; BLEEDING; CAREGIVER; DISEASE SURVEILLANCE; EBOLA HEMORRHAGIC FEVER; EPISTAXIS; FATIGUE; FEVER; FLUID RESUSCITATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GRANULOCYTE COUNT; HEALTH CARE FACILITY; HEALTH STATUS; HEMATEMESIS; HOSPITAL ADMISSION; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MEDICAL EDUCATION; MELENA; MORBIDITY; PATIENT CARE; PHYSICIAN; REAL TIME POLYMERASE CHAIN REACTION; RESUSCITATION; SEIZURE; SIERRA LEONE; UNITED KINGDOM; VAGINA BLEEDING; VIRUS LOAD; VOMITING; WORLD HEALTH ORGANIZATION; BLOOD; EPIDEMIC; HEALTH CARE DELIVERY; MORTALITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DELIVERY OF HEALTH CARE; DISEASE OUTBREAKS; FEMALE; HEALTH STATUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SIERRA LEONE; TREATMENT OUTCOME;

EID: 84988517536     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2210.160579     Document Type: Article

References (40)

1. World Health Organization. Ebola data and statistics [cited 2015 Sep 18]. http://apps.who.int/gho/data/node.ebola-sitrep.quick-downloads?lang=en
2. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054–7. http://dx.doi.org/10.1056/NEJMp1413084
3. Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, et al.; WHO Ebola Response Team. Ebola virus disease among children in West Africa. N Engl J Med. 2015;372:1274–7. http://dx.doi.org/10.1056/NEJMc1415318
4. Mupere E, Kaducu OF, Yoti Z. Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001;1:60–5.
5. WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481–95. http://dx.doi.org/10.1056/NEJMoa1411100
6. Johnson O, Brown CS, Lado M, Wurie A, Bash-Taqi D, Hall A, et al. Ebola holding units at government hospitals in Sierra Leone: evidence for a flexible and effective model for safe isolation, early treatment initiation, hospital safety, and health system functioning. BMJ Global Health. 2016;1:e000030 http://dx.doi.org/10.1136/bmjgh-2016-000030.
7. Brown C, Kessete Q, Baker P, Youkee D, Walker N, Kamara TB, et al. Bottlenecks in health systems functioning for control of Ebola virus disease in Connaught Hospital, Freetown, Sierra Leone. Poster P0092. Presented at: 26th European Congress of Clinical Microbiology and Infectious Diseases; 2016 Apr 9–12; Amsterdam, the Netherlands.
8. Fitzgerald F, Awonuga W, Shah T, Youkee D. Ebola response in Sierra Leone: the impact on children. J Infect. 2016;72(Suppl):S6–12. http://dx.doi.org/10.1016/j.jinf.2016.04.016
9. Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, et al.; WHO Ebola Response Team. West African Ebola epidemic after one year—slowing but not yet under control. N Engl J Med. 2015;372:584–7. http://dx.doi.org/10.1056/NEJMc1414992
10. Dietz PM, Jambai A, Paweska JT, Yoti Z, Ksiazek TG. Epidemiology and risk factors for Ebola virus disease in Sierra Leone— 23 May 2014 to 31 January 2015. Clin Infect Dis. 2015;61:1648–54.
11. Ansumana R, Jacobsen KH, Sahr F, Idris M, Bangura H, Boie-Jalloh M, et al. Ebola in Freetown area, Sierra Leone— a case study of 581 patients. N Engl J Med. 2015;372:587–8. http://dx.doi.org/10.1056/NEJMc1413685
12. Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15:1292–9. http://dx.doi.org/10.1016/S1473-3099(15)00144-9
13. Lado M, Walker NF, Baker P, Haroon S, Brown CS, Youkee D, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015;15:1024–33. http://dx.doi.org/10.1016/S1473-3099(15)00137-1
14. MacDermott NE, De S, Herberg JA. Viral haemorrhagic fever in children. Arch Dis Child. 2016;101:461–8. http://dx.doi.org/10.1136/archdischild-2014-307861
15. World Health Organization. Clinical management of patients in the Ebola treatment centres and other care centres in Sierra Leone: a pocket guide. Interim emergency guidelines. Sierra Leone adaptation. Geneva: The Organization; 2014
16. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371:2394–401. http://dx.doi.org/10.1056/NEJMoa1411677
17. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377–99. http://dx.doi.org/10.1002/sim.4067
18. Qin E, Bi J, Zhao M, Wang Y, Guo T, Yan T, et al. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis. 2015;61:491–5. http://dx.doi.org/10.1093/cid/civ319
19. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, et al. Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis. 2014;20:1683–90. http://dx.doi.org/10.3201/eid2010.140430
20. Olupot-Olupot P. Ebola in children: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J. 2015;34:314–6. http://dx.doi.org/10.1097/INF.0000000000000638
21. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis. 1999;179(Suppl 1):S24–7. http://dx.doi.org/10.1086/514311
22. Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA. What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol. 2014;124:1005–10. http://dx.doi.org/10.1097/AOG.0000000000000533
23. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56:271–93.
24. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40–7. http://dx.doi.org/10.1056/NEJMoa1411249
25. Sissoko D, Laouenan C, Folkesson E, M’Lebing AB, Beavogui AH, Baize S, et al.; JIKI Study Group. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967. http://dx.doi.org/10.1371/journal.pmed.1001967
26. de La Vega MA, Caleo G, Audet J, Qiu X, Kozak RA, Brooks JI, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest. 2015;125:4421–8. http://dx.doi.org/10.1172/JCI83162
27. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, et al. ReEBOV Antigen Rapid Test kit for point-ofcare and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386:867–74. http://dx.doi.org/10.1016/S0140-6736(15)61042-X
28. Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, et al. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016;42:34–9. http://dx.doi.org/10.1016/j.ijid.2015.10.021
29. Gignoux E, Azman AS, de Smet M, Azuma P, Massaquoi M, Job D, et al. Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 2016;374:23–32. http://dx.doi.org/10.1056/NEJMoa1504605
30. Owens S, Leyland T. Fighting Ebola in Sierra Leone: a view from the frontline. Arch Dis Child. 2016;101:284–6. http://dx.doi.org/10.1136/archdischild-2015-308330
31. Aswani V. Being a pediatrician in an Ebola epidemic. Pediatrics. 2016;137:e20152950. Epub 2015 Dec 1. http://dx.doi.org/10.1542/peds.2015-2950
32. Francia M. Surviving together, in Ebola-hit Sierra Leone [cited 2015 Nov 13]. http://www.unicef.org/infobycountry/sierraleone_80800.html
33. Epstein JM, Sauer LM, Chelen J, Hatna E, Parker J, Rothman RE, et al. Infectious disease: mobilizing Ebola survivors to curb the epidemic. Nature. 2014;516:323–5. http://dx.doi.org/10.1038/516323a
34. Dowell SF. Ebola hemorrhagic fever: why were children spared? Pediatr Infect Dis J. 1996;15:189–91. http://dx.doi.org/10.1097/00006454-199603000-00002
35. Peacock G, Uyeki TM, Rasmussen SA. Ebola virus disease and children: what pediatric health care professionals need to know. JAMA Pediatr. 2014;168:1087–8. http://dx.doi.org/10.1001/jamapediatrics.2014.2835
36. Glynn JR. Age-specific incidence of Ebola virus disease. Lancet. 2015;386:432. http://dx.doi.org/10.1016/S0140-6736(15)61446-5
37. Barry M, Traoré FA, Sako FB, Kpamy DO, Bah EI, Poncin M, et al. Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features. Med Mal Infect. 2014;44:491–4. http://dx.doi.org/10.1016/j.medmal.2014.09.009
38. Helleringer S, Noymer A, Clark SJ, McCormick T. Did Ebola relatively spare children? Lancet. 2015;386:1442–3. http://dx.doi.org/10.1016/S0140-6736(15)00415-8
39. Fitzgerald F, Yeung S, Gibb DM, Baion DE, Pollard A. Ebola vaccination. Lancet. 2015;386:2478. http://dx.doi.org/10.1016/S0140-6736(15)01243-X
40. Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group. Ebola vaccination— authors’ reply. Lancet. 2015;386:2480. http://dx.doi.org/10.1016/S0140-6736(15)00951-4